Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 5, 2011, Pages 384-395

  Kawahara, Tetsuya ^a   Nishikawa, Masako ^b   Furusawa, Tetsuya ^a   Inazu, Tetsuya ^c   Suzuki, Gen ^d  

^a Japan Organization of Occupational Health and Safety   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c RITSUMEIKAN UNIVERSITY   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Aortic plaque; Atherosclerosis; Atorvastatin; Bisphosphonate; Etidronate

Indexed keywords

ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA; ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THORACIC AORTA; TREATMENT OUTCOME;

AORTA; BONE DENSITY CONSERVATION AGENTS; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PYRROLES; TREATMENT OUTCOME;

EID: 79958072606     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7104     Document Type: Article

References (32)

1. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med, 2005; 352: 29-38
2. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Che-sebro J, Mercuri M, Badimon JJ: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation, 2001; 104: 249-252
3. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ: Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation, 2002; 106: 2884-2887
4. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H: Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004; 110: 1061-1068
5. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohm-ori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F: Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Car-diol, 2005; 45: 733-742
6. Schwartz CJ, Mitchell JR: Observations on localization of arterial plaques. Circ Res, 1962; 11: 63-73
7. Overturf M, Sybers H, Schaper J, Taegtmeyer H: Hypertension and atherosclerosis in cholesterol-fed rabbits. Part 1. Mild, two-kidney, one-clip Goldblatt hypertension treated with enalapril. Atherosclerosis, 1986; 59: 283-299
8. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP: Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol, 1997; 17: 95-106
9. Reaven PD, Sacks J: Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia, 2005; 48: 379-385
10. Allison MA, Criqui MH, Wright CM: Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol, 2004; 24: 331-336
11. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel D P, Han-nan M, Polak JM, Cupples LA: Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation, 2001; 103: 1529-1534
12. Wagenknecht LE, Langefeld CD, Freedman BI, Carr JJ, Bowden DW: A comparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid, and abdominal aortic arteries: the diabetes heart study. Am J Epidemiol, 2007; 166: 340-347
13. Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H: Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis, 2004; 44: 680-688
14. Shiraishi N, Kitamura K, Miyoshi T, Adachi M, Kohda Y, Nonoguchi H, Misumi S, Maekawa Y, Murayama T, Tomita M, Tomita K: Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis, 2006; 48: 151-154
15. Rosenblum IY, Flora L, Eisenstein R: The effect of diso-dium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. Atherosclerosis, 1975; 22: 411-424
16. Kramsch DM, Aspen AJ, Rozler LJ: Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science, 1981; 213: 1511-1512
17. Ylitalo R, Oksala O, Yla-Herttuala S, Ylitalo P: Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J Lab Clin Med, 1994; 123: 769-776
18. Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J: Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab, 2000; 85: 2793-2796
19. Farhat GN, Cauley JA, Matthews KA, Newman AB, Johnston J, Mackey R, Edmundowicz D, Sutton-Tyrrell K: Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res, 2006; 21: 1839-1846
20. Farhat GN, Strotmeyer ES, Newman AB, Sutton-Tyrrell K, Bauer DC, Harris T, Johnson KC, Taaffe DR, Cauley JA: Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study. Calcif Tissue Int, 2006; 79: 102-111
21. Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fuji-wara S, Miki T, Sagawa A, Nishizawa Y, Seino Y: Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab, 2005; 23: 105-109
22. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V: In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation, 2000; 101: 2503-2509
23. Taniguchi H, Momiyama Y, Fayad ZA, Ohmori R, Ashida K, Kihara T, Hara A, Arakawa K, Kameyama A, Noya K, Nagata M, Nakamura H, Ohsuzu F: In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J, 2004; 148: 137-143
24. Li AE, Kamel I, Rando F, Anderson M, Kumbasar B, Lima JA, Bluemke DA: Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR Am J Roentgenol, 2004; 182: 593-597
25. Toussaint JF, LaMuraglia GM, Southern J F, Fuster V, Kantor HL: Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation, 1996; 94: 932-938
26. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roque M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ: High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis, 2000; 150: 321-329
27. Tribouilloy CM, Peltier M, Iannetta-Peltier MC, Zhu Z, Andrejak M, Lesbre JP: Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. Am J Cardiol, 1999; 84: 603-605, A609
28. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon AC: Risk factors and early extra-coronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prevention Cardio-vasculaire en Medecine du Travail METRA Group. Arch Intern Med, 1991; 151: 950-956
29. Francis MD, Flora L, King WR: The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in rats. Calcif Tissue Res, 1972; 9: 109-121
30. Delibasi T, Emral R, Erdogan MF, Kamel N: Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis. Adv Ther, 2007; 24: 319-325
31. Tanko LB, Qin G, Alexandersen P, Bagger YZ, Christiansen C: Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteo-porotic women. Osteoporos Int, 2005; 16: 184-190
32. Kanazawa I, Yamaguchi T, Hayashi K, Takase H, Shimizu T, Sugimoto T: Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmeno-pausal women with type 2 diabetes mellitus accompanied with osteoporosis. Am J Med Sci, 2010; 339: 519-524